700 related articles for article (PubMed ID: 24193080)
1. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels.
Vigen R; O'Donnell CI; Barón AE; Grunwald GK; Maddox TM; Bradley SM; Barqawi A; Woning G; Wierman ME; Plomondon ME; Rumsfeld JS; Ho PM
JAMA; 2013 Nov; 310(17):1829-36. PubMed ID: 24193080
[TBL] [Abstract][Full Text] [Related]
2. Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men.
Sharma R; Oni OA; Gupta K; Chen G; Sharma M; Dawn B; Sharma R; Parashara D; Savin VJ; Ambrose JA; Barua RS
Eur Heart J; 2015 Oct; 36(40):2706-15. PubMed ID: 26248567
[TBL] [Abstract][Full Text] [Related]
3. Nonobstructive coronary artery disease and risk of myocardial infarction.
Maddox TM; Stanislawski MA; Grunwald GK; Bradley SM; Ho PM; Tsai TT; Patel MR; Sandhu A; Valle J; Magid DJ; Leon B; Bhatt DL; Fihn SD; Rumsfeld JS
JAMA; 2014 Nov; 312(17):1754-63. PubMed ID: 25369489
[TBL] [Abstract][Full Text] [Related]
4. Re: association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels.
Seftel A; Penson DF
J Urol; 2014 Jul; 192(1):177-8. PubMed ID: 25629106
[No Abstract] [Full Text] [Related]
5. Testosterone treatment and mortality in men with low testosterone levels.
Shores MM; Smith NL; Forsberg CW; Anawalt BD; Matsumoto AM
J Clin Endocrinol Metab; 2012 Jun; 97(6):2050-8. PubMed ID: 22496507
[TBL] [Abstract][Full Text] [Related]
6. Effects of Testosterone Administration for 3 Years on Subclinical Atherosclerosis Progression in Older Men With Low or Low-Normal Testosterone Levels: A Randomized Clinical Trial.
Basaria S; Harman SM; Travison TG; Hodis H; Tsitouras P; Budoff M; Pencina KM; Vita J; Dzekov C; Mazer NA; Coviello AD; Knapp PE; Hally K; Pinjic E; Yan M; Storer TW; Bhasin S
JAMA; 2015 Aug; 314(6):570-81. PubMed ID: 26262795
[TBL] [Abstract][Full Text] [Related]
7. Deaths and cardiovascular events in men receiving testosterone.
Dhindsa S; Batra M; Dandona P
JAMA; 2014 Mar; 311(9):964. PubMed ID: 24595787
[No Abstract] [Full Text] [Related]
8. Deaths and cardiovascular events in men receiving testosterone.
Katz J; Nadelberg R
JAMA; 2014 Mar; 311(9):963. PubMed ID: 24595786
[No Abstract] [Full Text] [Related]
9. Deaths and cardiovascular events in men receiving testosterone.
Riche DM; Baker WL; Koch CA
JAMA; 2014 Mar; 311(9):963-4. PubMed ID: 24595785
[No Abstract] [Full Text] [Related]
10. Deaths and cardiovascular events in men receiving testosterone.
Jones TH; Channer KS
JAMA; 2014 Mar; 311(9):962-3. PubMed ID: 24595784
[No Abstract] [Full Text] [Related]
11. Deaths and cardiovascular events in men receiving testosterone.
Morgentaler A; Traish A; Kacker R
JAMA; 2014 Mar; 311(9):961-2. PubMed ID: 24595783
[No Abstract] [Full Text] [Related]
12. Deaths and cardiovascular events in men receiving testosterone--reply.
Ho PM; Barón AE; Wierman ME
JAMA; 2014 Mar; 311(9):964-5. PubMed ID: 24595788
[No Abstract] [Full Text] [Related]
13. Impact of Testosterone Replacement Therapy on Myocardial Infarction, Stroke, and Death in Men With Low Testosterone Concentrations in an Integrated Health Care System.
Anderson JL; May HT; Lappé DL; Bair T; Le V; Carlquist JF; Muhlestein JB
Am J Cardiol; 2016 Mar; 117(5):794-9. PubMed ID: 26772440
[TBL] [Abstract][Full Text] [Related]
14. Testosterone therapy and risk of cardiovascular disease in men.
Cappola AR
JAMA; 2013 Nov; 310(17):1805-6. PubMed ID: 24193077
[No Abstract] [Full Text] [Related]
15. Association of Testosterone Replacement With Cardiovascular Outcomes Among Men With Androgen Deficiency.
Cheetham TC; An J; Jacobsen SJ; Niu F; Sidney S; Quesenberry CP; VanDenEeden SK
JAMA Intern Med; 2017 Apr; 177(4):491-499. PubMed ID: 28241244
[TBL] [Abstract][Full Text] [Related]
16. Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone.
Budoff MJ; Ellenberg SS; Lewis CE; Mohler ER; Wenger NK; Bhasin S; Barrett-Connor E; Swerdloff RS; Stephens-Shields A; Cauley JA; Crandall JP; Cunningham GR; Ensrud KE; Gill TM; Matsumoto AM; Molitch ME; Nakanishi R; Nezarat N; Matsumoto S; Hou X; Basaria S; Diem SJ; Wang C; Cifelli D; Snyder PJ
JAMA; 2017 Feb; 317(7):708-716. PubMed ID: 28241355
[TBL] [Abstract][Full Text] [Related]
17. Invasive coronary procedure use and outcomes among veterans with posttraumatic stress disorder: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.
Bradley SM; Stanislawski MA; Bekelman DB; Monteith LL; Cohen BE; Schilling JH; Hunt SC; Milek D; Maddox TM; Ho PM; Shore S; Varosy PD; Matthieu MM; Rumsfeld JS
Am Heart J; 2014 Sep; 168(3):381-390.e6. PubMed ID: 25173551
[TBL] [Abstract][Full Text] [Related]
18. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.
Feres F; Costa RA; Abizaid A; Leon MB; Marin-Neto JA; Botelho RV; King SB; Negoita M; Liu M; de Paula JE; Mangione JA; Meireles GX; Castello HJ; Nicolela EL; Perin MA; Devito FS; Labrunie A; Salvadori D; Gusmão M; Staico R; Costa JR; de Castro JP; Abizaid AS; Bhatt DL;
JAMA; 2013 Dec; 310(23):2510-22. PubMed ID: 24177257
[TBL] [Abstract][Full Text] [Related]
19. Testosterone, cardiovascular disease, and mortality in men: living in the dark.
Page ST
Lancet Diabetes Endocrinol; 2014 Aug; 2(8):609-11. PubMed ID: 24785643
[No Abstract] [Full Text] [Related]
20. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.
Bangalore S; Steg G; Deedwania P; Crowley K; Eagle KA; Goto S; Ohman EM; Cannon CP; Smith SC; Zeymer U; Hoffman EB; Messerli FH; Bhatt DL;
JAMA; 2012 Oct; 308(13):1340-9. PubMed ID: 23032550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
